[Paper Review] Genotyping coronavirus SARS-CoV-2: methods and implications

Changchuan Yin|arXiv (Cornell University)|Mar 24, 2020

SARS-CoV-2 and COVID-19 Research34 references18 citations

TL;DR

This paper presents a genotyping method for SARS-CoV-2 using multiple sequence alignment (MSA) of complete genomes and Jaccard distance-based SNP profiling to track viral evolution and transmission. The approach identifies frequent mutations in key viral proteins—S protein, RNA polymerase, RNA primase, and nucleoprotein—highlighting critical targets for vaccine development and epidemic monitoring.

ABSTRACT

The emerging global infectious COVID-19 coronavirus disease by novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) presents critical threats to global public health and the economy since it was identified in late December 2019 in China. The virus has gone through various pathways of evolution. For understanding the evolution and transmission of SARS-CoV-2, genotyping of virus isolates is of great importance. We present an accurate method for effectively genotyping SARS-CoV-2 viruses using complete genomes. The method employs the multiple sequence alignments of the genome isolates with the SARS-CoV-2 reference genome. The SNP genotypes are then measured by Jaccard distances to track the relationship of virus isolates. The genotyping analysis of SARS-CoV-2 isolates from the globe reveals that specific multiple mutations are the predominated mutation type during the current epidemic. Our method serves a promising tool for monitoring and tracking the epidemic of pathogenic viruses in their gradual and local genetic variations. The genotyping analysis shows that the genes encoding the S proteins and RNA polymerase, RNA primase, and nucleoprotein, undergo frequent mutations. These mutations are critical for vaccine development in disease control.

Motivation & Objective

• To develop an accurate, scalable method for genotyping SARS-CoV-2 using complete viral genome sequences.
• To track the global spread and evolutionary dynamics of SARS-CoV-2 through SNP-based genotyping.
• To identify recurrent and prevalent mutations in critical viral proteins linked to transmissibility and pathogenesis.
• To support rapid surveillance and response by enabling real-time monitoring of viral genetic variation.
• To inform vaccine and therapeutic design by pinpointing conserved and variable regions in essential viral proteins.

Proposed method

• Performs multiple sequence alignment (MSA) of 558 SARS-CoV-2 complete genomes against the reference genome.
• Computes single nucleotide polymorphism (SNP) profiles from aligned genomes to identify variant positions.
• Applies directed Jaccard distance to quantify genetic similarity and infer phylogenetic relationships among isolates.
• Uses complete genome data to ensure high-resolution SNP calling and minimize false positives.
• Validated the method on global isolates from December 2019 to March 2020, covering 14 transmission generations.
• Considers both SNPs and rare insertion/deletion events, though with limited data on indel propagation.

Experimental results

Research questions

• RQ1 Which genomic regions of SARS-CoV-2 exhibit the highest frequency of mutations during the early pandemic phase?
• RQ2 How can complete genome sequences be leveraged to accurately genotype and track SARS-CoV-2 isolates across global populations?
• RQ3 What is the relationship between specific SNP profiles and geographic or temporal clusters of infection?
• RQ4 Which viral proteins are most prone to mutation, and how might these mutations affect viral fitness or immune escape?
• RQ5 Can SNP signatures derived from Jaccard distance analysis reliably predict transmission patterns and lineage spread?

Key findings

• The method successfully genotyped 558 SARS-CoV-2 isolates from 147 countries as of March 23, 2020, enabling global surveillance.
• Frequent co-mutations (241C→T, 3037C→T, 23403A→G) were predominantly found in European isolates, correlating with high transmission and severe outcomes.
• The S protein, RNA polymerase (nsp12), RNA primase (nsp8), and nucleoprotein (N) were the most frequently mutated genes.
• One mutation per viral generation was estimated, with up to 14 mutations observed in a single lineage over 3.5 months (Dec 2019–Mar 2020), indicating ~14 transmission generations.
• A case in Illinois, USA, showed a single mutation (28854C→Y) between two closely spaced infections, supporting the method’s resolution in transmission tracking.
• Deletion and insertion mutations were rare but observed; their potential for spread remains uncertain due to limited genomic data.